The first Edwards Lifesciences trade was made in Q2 2018. Since then AKO Capital bought shares five more times and sold shares on three occasions. The investor completely sold their stake between Q1 2020 and Q2 2020.
Northwest Capital Management Inc acquired a new position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) during the 2nd quarter, according to i...
The AM Reporter, 5 months agoChicago Capital LLC lowered its holdings in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 0.6% during the second quarter, HoldingsChannel.com...
The AM Reporter, 6 months agoGoldman Sachs boosted the price target on Reata Pharmaceuticals, Inc. (NASDAQ: RETA ) from $86 to $115. Goldman Sachs analyst Madhu Kumar maintained the stoc...
Benzinga, over 1 year ago